共 35 条
Perylene diimide-POSS network for semi selective solid-phase microextraction of lung cancer biomarkers in exhaled breath
被引:18
作者:
Soufi, Gohar
[1
]
Bagheri, Habib
[1
]
Rad, Ladan Yeganeh
[1
]
Minaeian, Sara
[2
]
机构:
[1] Sharif Univ Technol, Dept Chem, Environm & Bioanalyt Labs, POB 11365-9516, Tehran, Iran
[2] Iran Univ Med Sci, Antimicrobial Resistance Res Ctr, Inst Immunol & Infect Dis, POB 1445613131, Tehran, Iran
关键词:
Exhaled breath analysis;
Biomarkers;
POSSs;
Lung cancer;
ALDEHYDES;
NANOPARTICLES;
METABOLITES;
FILM;
D O I:
10.1016/j.aca.2022.339550
中图分类号:
O65 [分析化学];
学科分类号:
070302 ;
081704 ;
摘要:
Lung cancer (LC) is the leading cause of cancer mortality so, the analysis of exhaled human breath has great significance for early non-invasive diagnosis. Poor selectivity and strong humidity are two bottlenecks for the application of gas sensors to exhaled breath analysis. The development of novel extractive phases for the analysis of exhaled breath by chromatography is therefore a lucrative object. Polyhedral oligomeric silsesquioxanes (POSS) are among the 3D porous materials whose unique properties make them promising coatings for solid-phase microextraction (SPME). Selective enrichment of polar or nonpolar targets depends on the pore size and functional groups on the POSSs. Herein, we disclosed 3D network of POSS-naphthalene diimide (POSS-NDI) and perylene diimide (POSS-PDI) as extractive phases for analysis of lung cancer biomarkers with the capability of capturing different volatile organic compounds (VOCs). The synthesized diimides were fully characterized by FT-IR, multinuclear NMR, SEM, TEM, TGA, and BET analysis. After optimization of all the influential parameters on sorption/desorption, figures of merit for three aldehydes as biomarkers of LC were obtained. The exhaled breath of twelve participants including seven healthy candidates and five cases with LC were examined. The partial least squares-discriminant analysis (PLS-DA) was implemented which led to the proper classification of healthy and LC patients with R-2 calibration and cross-validation of 0.9738 and 0.7882, respectively. (C) 2022 Elsevier B.V. All rights reserved.
引用
收藏
页数:9
相关论文